Bard Associates Inc Pet Vivo Holdings, Inc. Transaction History

Bard Associates Inc

  • $267 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.99 - $1.46 $2,663 - $3,927
-2,690 Reduced 0.64%
418,795 $448,000
Q3 2023

Nov 13, 2023
SELL
$1.72 - $2.45 $25,825 - $36,786
-15,015 Reduced 3.44%
421,485 $775,000
Q2 2023

Aug 11, 2023
BUY
$1.89 - $2.92 $824,985 - $1.27 Million
436,500 New
436,500 $859,000

About PetVivo Holdings, Inc.

PETV Quotes by TradingView
  • Ticker PETV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,072,000
  • Market Cap $5.04M
  • Description
  • PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...
More about PETV
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email